Bottom line
What is IDIVX's expense ratio?
IDIVX's expense ratio is 0.95%, or about $95 a year on every $10,000 invested. That is more expensive than 68% of dividend & equity income funds we track (median 0.74%). This share class also charges a front-end sales load of up to 5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Nov 26, 2025
IDIVX fee table
| Net expense ratio | 0.95% |
|---|---|
| Gross expense ratio | 1.4% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.4% |
| Fee waiver / reimbursement | -0.45% |
| Max front-end sales load | 5% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Nov 26, 2025
What IDIVX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IDIVX | $592 | $879 | $1,187 | $2,059 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.95% expense ratio costs roughly $52,800 in lost growth, versus about $41,900 for the median dividend & equity income fund (0.74%).